ILMN 4Q2010 In-Line With Preannouncement, Goldman Sachs Reports

Illumina, Inc. ILMN reported 4Q2010 revenue/EPS of $261 mn/$0.29, in-line with the 1/11 preannouncement. “This represents yoy revenue growth of 47%,” Goldman Sachs writes. “HiSeq unit production increased another 30% sequentially, positioning the company to reduce lead times as promised heading into FY2011. “Gross margins of 64.5% were 150 bps below our forecast as GA2 trade-ins continue to progress quickly. Management stated that the impact of trade-ins on GM's should abate in 1Q11 and we continue to expect FY2011 annualized GM's of 70%. In arrays, management cited a sequential decline in revenues but a 7% sequential increase in orders, due largely to timing.” Illumina closed Tuesday at $70.25.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Analyst RatingsGoldman SachsHealth CareilluminaLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!